James A. Schoeneck - 30 Jun 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Reporting relationship: Director
Issuer ticker: FGEN
Reported as of: 30 Jun 2025
Net transaction value: +$119,485
SEC form: 4
Accepted by SEC: 02 Jul 2025, 16:33:27 UTC
Prior SEC filing: 06 Jun 2025
Next SEC filing: 15 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Hom, Attorney-in-Fact

Key filing fact

James A. Schoeneck filed Form 4 for FIBROGEN INC (FGEN) on 02 Jul 2025.

Key facts

This page summarizes James A. Schoeneck's Form 4 filing for FIBROGEN INC (FGEN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2025, 16:33.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: +$119,485.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001420987 Primary reporting owner

Schoeneck James A

Relationship: Director
Address: C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO
Signature: /s/ Michael Hom, Attorney-in-Fact
Signature date: 02 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FGEN transaction

Common Stock

Purchase

Transaction value: $119,485
Shares: +23,567
Change %: +146%
Price: $5.07^*
Shares after: 39,666
Date: 30 Jun 2025
Ownership: By Trust
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.935 to $5.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Reflects a 1-for-25 reverse stock split effective on June 16, 2025.